Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
HDL Resource Center: A Component of the Residual Risk Reduction Initiative – Expert “Clinical Translations” Video Interview Series – Hot Topics in HDL—From Orlando 2011
Faculty
Chair
Robert S. Rosenson, MD, FACC, FAHA, FACP, FNLA
Robert S. Rosenson, MD, FACC, FAHA, FACP, FNLA
Director, Cardiometabolic Disorders
Mount Sinai Heart
Professor of Medicine
Mount Sinai School of Medicine
New York, New York
Co-chair
H. Bryan Brewer, Jr., MD
H. Bryan Brewer, Jr., MD
Director, Washington Cardiovascular Associates
Senior Research Consultant
Lipoprotein and Atherosclerosis Research
MedStar Research Institute
Washington Hospital Center
Washington, DC
Faculty
Philip J. Barter, MBBS, PhD, FRACP
Philip J. Barter, MBBS, PhD, FRACP
Director, The Heart Research Institute
Sydney, Australia
Professor of Medicine
University of Sydney, Australia
Accredited by
Medical Education Resources (MER)
Activity Details
| Release Date: | November, 2011 |
| Expiration Date: | November, 2012 |
| Credit Types: | CME |
| Credit Amount: | 0.75 AMA PRA Category 1 Credit(s)™ |
| Estimated Time for Completion: | 0.75 hours |
| Registration Required: | No |
| Cost: | Free |
Target Audience
This activity has been designed to meet the educational needs of cardiologists; diabetologists; primary care physicians (PCPs) including FPs/GPs/IMs; and allied health professionals (nurses, pharmacists, dietitians, NPs, PAs) involved in the care of patients with dyslipidemia, cardiovascular disease, or cardiovascular risk factors.
Statement of Need/Program Overview
The care of patients with cardiovascular disease (CVD) and/or diabetes is complex, and determining the best practices for these patients is an ongoing process. Therefore, it is paramount that physicians caring for these patients continue to receive education from lead researchers and clinicians in order to interpret the latest findings, implement best practices, and maximize patient outcomes. This activity will discuss recent advances in high-density lipoprotein-cholesterol complex (HDL-C) and review evidence for HDL-C as a therapeutic target to reduce the residual risk typical in statin-treated high-risk cardiovascular patients. Expert faculty presenters will include their perspectives and interpretations of emerging clinical trial data regarding the management of patients with low HDL-C.
Educational Objectives:
After completing this activity, the participant should be better able to:
- Summarize recent clinical trial data (AIM-HIGH and SATURN) related to therapeutic agents used in the treatment of patients with low HDL-C
"Hot Topics in HDL—From Orlando 2011” is a part of the HDL Resource Center: A Component of the Residual Risk Reduction Initiative “Clinical Translations" Video Series.
Program Co-chairs: Robert S. Rosenson, MD, FACC, FAHA, FACP, FNLA and
This activity consists of 2 interviews that interpret and provide clinical application of the most relevant and exciting data on HDL-C coming out of AHA 2011, primarily focusing on the AIM-HIGH and SATURN studies.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER), Residual Risk Reduction Initiative (R3i), and Consensus Medical Communications (CMC). MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation for “Hot Topics in HDL—From Orlando 2011”
Medical Education Resources designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
| Name of Faculty | Reported Financial Relationship |
| Robert S. Rosenson, MD, FACC, FAHA, FACP, FNLA | Grants/research support from Abbott, Genentech/Roche, Daiichi, Sankyo, Grain Food Board, sanofi-aventis, Residual Risk Reduction Initiative Foundation, and LipoScience. Holdings in LipoScience. |
| H. Bryan Brewer, Jr., MD | Grants/research support from Eli Lilly, Merck/Schering-Plough, Roche/Genentech, and sanofi-aventis. |
| Philip J. Barter, MBBS, PhD, FRACP | Grants/research support from Merck; consulting fees from AstraZeneca, Kowa, Merck, Novartis, Pfizer, and Roche. |
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
| Name of Content Manager | Reported Financial Relationship |
| Jennifer Frederick, PharmD, BCPS | No financial relationships to disclose |
| Julie Johnson, PharmD | No financial relationships to disclose |
Method of Participation
There are no fees for participating in and receiving CME credit for this activity. During the period November 2011 through November 2012, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest, and 4) complete the evaluation form.
A statement of credit will be issued only upon electronic submission of a completed activity evaluation form and a completed posttest with a score of 70% or better. Statements of credit should be printed online upon completion via the MER website.
Media
Internet
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Residual Risk Reduction Initiative (R3i), Consensus Medical Communications (CMC), or Genentech. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, R3i, CMC, and Genentech. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Support/Sponsor Verbiage
This activity is jointly sponsored by Medical Education Resources (MER) and Residual Risk Reduction Initiative (R3i) in collaboration with Consensus Medical Communications (CMC).
This activity is supported by an educational grant from Genentech.
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
